iLB-C16bm-s6 edit BAG3 E2
UKBi015-A-6
General
Cell Line |
|
hPSCreg name | UKBi015-A-6 |
Cite as: | UKBi015-A-6 |
Alternative name(s) |
iLB-C16bm-s6 edit BAG3 E2
|
Cell line type | Human induced pluripotent stem cell (hiPSC) |
Similar lines | No similar lines found. |
Last update | 20th August 2024 |
Notes | Internal experimental control was generated undergoing the same experimental procedure and is registered as UKBi015-A-8. |
User feedback | |
Provider |
|
Generator |
Universitätsklinikum Bonn (UKB)
Contact:
Institute of Physiology I |
Owner | Institute of Physiology I |
Distributors | |
Derivation country | Germany |
External Databases |
|
BioSamples | SAMEA115753180 |
General Information |
|
* Is the cell line readily obtainable for third parties? |
No |
Subclone of |
Donor Information
General Donor Information |
|
Sex | male |
Ethnicity | caucasian |
Phenotype and Disease related information (Donor) |
|
Diseases | No disease was diagnosed.
|
Donor Relations |
|
Other cell lines of this donor | |
External Databases (Donor) |
|
BioSamples | SAMEA7222555 |
Ethics
Also have a look at the ethics information for the parental line
UKBi015-A
.
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? |
hIPSC Derivation
General |
|
The source cell information can be found in the parental cell line
UKBi015-A.
|
|
Reprogramming method |
|
Vector type | Non-integrating |
Vector | Sendai virus |
Genes | |
Is reprogramming vector detectable? |
No |
Methods used |
PCR
|
Vector map | |
Vector free reprogramming |
|
Other |
|
Derived under xeno-free conditions |
Unknown |
Derived under GMP? |
Unknown |
Available as clinical grade? |
Unknown |
Culture Conditions
Medium |
Other medium:
Base medium: StemMACS iPS Brew XF Medium
Main protein source: Serum concentration: % Supplements
|
Characterisation
Analysis of Undifferentiated Cells
Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles |
SSEA-1 |
Yes |
|
||||
POU5F1 (OCT-4) |
Yes |
|
||||
TRA 1-60 |
Yes |
|
Differentiation Potency
Microbiology / Virus Screening |
|
HIV 1 | Negative |
HIV 2 | Negative |
Hepatitis B | Negative |
Hepatitis C | Negative |
Mycoplasma | Negative |
Genotyping
Karyotyping (Cell Line) |
|
Has the cell line karyotype been analysed? |
Yes
|
Other Genotyping (Cell Line) |
Genetic Modification
Disease/phenotype related modifications |
|
Login to share your feedback, experiences or results with the research community.